As the days of the Bush Adminstration comes to a close Dr. Elias A. Zerhouni, Director of the National Institutes of Health (NIH), has decided to step down at the end of October.
The fate of the FY 08 emergency supplemental appropriations bill in the House was finally decided last night. Leaders on both sides negotiated a deal and came up with a bill that will likely be signed by the President.
The Food and Drug Administration (FDA) was one of the big winners, snagging an additional $150 million. A much lower number than we had hoped for, but a victory nonetheless.
As I reported yesterday, the Bush administration amended the FY 09 budget to include an extra $275 million for the Food and Drug (FDA) Administration. A valid attempt to make the situation right, it seems it may be too little too late.
In a letter from Senator Arlen Specter (R-PA) to Secretary Michael Leavitt (Health and Human Services), Specter said the FDA’s request on Monday for an additional $275 million wouldn’t give them any money until March or April 2009 “at the earliest.”
We are very pleased to announce that the Administration has taken the highly unusual step of amending its FY 2009 budget to include an additional $275 million for the FDA.
Last month we let you know the Food and Drug Administration (FDA) Chief, Andrew Von Eschenbach, wrote a letter to Senator Arlen Specter (R-PA) expressing the dire need of an influx of $275 million. This was very unusual for a political appointee to go against the proposed budget of the President.